nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Ototoxicity—Vinorelbine—ovarian cancer	0.0769	0.0769	CcSEcCtD
Capreomycin—Ototoxicity—Paclitaxel—ovarian cancer	0.0517	0.0517	CcSEcCtD
Capreomycin—Ototoxicity—Docetaxel—ovarian cancer	0.0438	0.0438	CcSEcCtD
Capreomycin—Foetor hepaticus—Melphalan—ovarian cancer	0.0311	0.0311	CcSEcCtD
Capreomycin—Nephropathy toxic—Vinorelbine—ovarian cancer	0.0269	0.0269	CcSEcCtD
Capreomycin—Liver disorder—Melphalan—ovarian cancer	0.0259	0.0259	CcSEcCtD
Capreomycin—Induration—Paclitaxel—ovarian cancer	0.0232	0.0232	CcSEcCtD
Capreomycin—Vertigo—Altretamine—ovarian cancer	0.0224	0.0224	CcSEcCtD
Capreomycin—Leukopenia—Altretamine—ovarian cancer	0.0223	0.0223	CcSEcCtD
Capreomycin—Injection site haemorrhage—Epirubicin—ovarian cancer	0.022	0.022	CcSEcCtD
Capreomycin—Injection site haemorrhage—Doxorubicin—ovarian cancer	0.0204	0.0204	CcSEcCtD
Capreomycin—Thrombocytopenia—Altretamine—ovarian cancer	0.0199	0.0199	CcSEcCtD
Capreomycin—Nephropathy toxic—Paclitaxel—ovarian cancer	0.0181	0.0181	CcSEcCtD
Capreomycin—Hepatocellular injury—Melphalan—ovarian cancer	0.0177	0.0177	CcSEcCtD
Capreomycin—Hypomagnesaemia—Paclitaxel—ovarian cancer	0.0163	0.0163	CcSEcCtD
Capreomycin—Hearing impaired—Vinorelbine—ovarian cancer	0.0162	0.0162	CcSEcCtD
Capreomycin—Foetor hepaticus—Docetaxel—ovarian cancer	0.0155	0.0155	CcSEcCtD
Capreomycin—Liver disorder—Docetaxel—ovarian cancer	0.0129	0.0129	CcSEcCtD
Capreomycin—Deafness—Vinorelbine—ovarian cancer	0.0125	0.0125	CcSEcCtD
Capreomycin—Pain—Carboplatin—ovarian cancer	0.012	0.012	CcSEcCtD
Capreomycin—Hypocalcaemia—Paclitaxel—ovarian cancer	0.0113	0.0113	CcSEcCtD
Capreomycin—Body temperature increased—Carboplatin—ovarian cancer	0.0111	0.0111	CcSEcCtD
Capreomycin—Hearing impaired—Paclitaxel—ovarian cancer	0.0109	0.0109	CcSEcCtD
Capreomycin—Urine abnormality—Epirubicin—ovarian cancer	0.0107	0.0107	CcSEcCtD
Capreomycin—Urine analysis abnormal—Epirubicin—ovarian cancer	0.0101	0.0101	CcSEcCtD
Capreomycin—Urine abnormality—Doxorubicin—ovarian cancer	0.00992	0.00992	CcSEcCtD
Capreomycin—Oliguria—Docetaxel—ovarian cancer	0.00955	0.00955	CcSEcCtD
Capreomycin—Hypomagnesaemia—Epirubicin—ovarian cancer	0.00934	0.00934	CcSEcCtD
Capreomycin—Urine analysis abnormal—Doxorubicin—ovarian cancer	0.00934	0.00934	CcSEcCtD
Capreomycin—Hearing impaired—Docetaxel—ovarian cancer	0.00924	0.00924	CcSEcCtD
Capreomycin—Hepatocellular injury—Docetaxel—ovarian cancer	0.0088	0.0088	CcSEcCtD
Capreomycin—Hypomagnesaemia—Doxorubicin—ovarian cancer	0.00864	0.00864	CcSEcCtD
Capreomycin—Deafness—Paclitaxel—ovarian cancer	0.00842	0.00842	CcSEcCtD
Capreomycin—Leukopenia—Chlorambucil—ovarian cancer	0.00793	0.00793	CcSEcCtD
Capreomycin—Renal impairment—Paclitaxel—ovarian cancer	0.00792	0.00792	CcSEcCtD
Capreomycin—Abscess—Epirubicin—ovarian cancer	0.0075	0.0075	CcSEcCtD
Capreomycin—Deafness—Docetaxel—ovarian cancer	0.00714	0.00714	CcSEcCtD
Capreomycin—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00708	0.00708	CcSEcCtD
Capreomycin—Leukopenia—Topotecan—ovarian cancer	0.00706	0.00706	CcSEcCtD
Capreomycin—Abscess—Doxorubicin—ovarian cancer	0.00694	0.00694	CcSEcCtD
Capreomycin—Leukopenia—Melphalan—ovarian cancer	0.00691	0.00691	CcSEcCtD
Capreomycin—Hypokalaemia—Paclitaxel—ovarian cancer	0.00686	0.00686	CcSEcCtD
Capreomycin—Renal impairment—Docetaxel—ovarian cancer	0.00671	0.00671	CcSEcCtD
Capreomycin—Hypocalcaemia—Epirubicin—ovarian cancer	0.00648	0.00648	CcSEcCtD
Capreomycin—Oliguria—Epirubicin—ovarian cancer	0.00644	0.00644	CcSEcCtD
Capreomycin—Thrombocytopenia—Topotecan—ovarian cancer	0.0063	0.0063	CcSEcCtD
Capreomycin—Pain—Chlorambucil—ovarian cancer	0.00618	0.00618	CcSEcCtD
Capreomycin—Thrombocytopenia—Melphalan—ovarian cancer	0.00617	0.00617	CcSEcCtD
Capreomycin—Vertigo—Vinorelbine—ovarian cancer	0.00606	0.00606	CcSEcCtD
Capreomycin—Leukopenia—Vinorelbine—ovarian cancer	0.00604	0.00604	CcSEcCtD
Capreomycin—Hypocalcaemia—Doxorubicin—ovarian cancer	0.006	0.006	CcSEcCtD
Capreomycin—Oliguria—Doxorubicin—ovarian cancer	0.00596	0.00596	CcSEcCtD
Capreomycin—Hepatocellular injury—Epirubicin—ovarian cancer	0.00593	0.00593	CcSEcCtD
Capreomycin—Urticaria—Chlorambucil—ovarian cancer	0.00574	0.00574	CcSEcCtD
Capreomycin—Body temperature increased—Chlorambucil—ovarian cancer	0.00571	0.00571	CcSEcCtD
Capreomycin—Renal failure—Paclitaxel—ovarian cancer	0.00571	0.00571	CcSEcCtD
Capreomycin—Pain—Topotecan—ovarian cancer	0.0055	0.0055	CcSEcCtD
Capreomycin—Hepatocellular injury—Doxorubicin—ovarian cancer	0.00549	0.00549	CcSEcCtD
Capreomycin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00539	0.00539	CcSEcCtD
Capreomycin—Pain—Melphalan—ovarian cancer	0.00539	0.00539	CcSEcCtD
Capreomycin—Hypersensitivity—Chlorambucil—ovarian cancer	0.00533	0.00533	CcSEcCtD
Capreomycin—Urticaria—Topotecan—ovarian cancer	0.00511	0.00511	CcSEcCtD
Capreomycin—Body temperature increased—Topotecan—ovarian cancer	0.00509	0.00509	CcSEcCtD
Capreomycin—Urticaria—Melphalan—ovarian cancer	0.00501	0.00501	CcSEcCtD
Capreomycin—Tinnitus—Paclitaxel—ovarian cancer	0.00486	0.00486	CcSEcCtD
Capreomycin—Renal failure—Docetaxel—ovarian cancer	0.00484	0.00484	CcSEcCtD
Capreomycin—Hypersensitivity—Topotecan—ovarian cancer	0.00474	0.00474	CcSEcCtD
Capreomycin—Pain—Vinorelbine—ovarian cancer	0.00471	0.00471	CcSEcCtD
Capreomycin—Hypersensitivity—Melphalan—ovarian cancer	0.00464	0.00464	CcSEcCtD
Capreomycin—Renal impairment—Epirubicin—ovarian cancer	0.00453	0.00453	CcSEcCtD
Capreomycin—Urticaria—Vinorelbine—ovarian cancer	0.00437	0.00437	CcSEcCtD
Capreomycin—Body temperature increased—Vinorelbine—ovarian cancer	0.00435	0.00435	CcSEcCtD
Capreomycin—Renal impairment—Doxorubicin—ovarian cancer	0.00419	0.00419	CcSEcCtD
Capreomycin—Vertigo—Paclitaxel—ovarian cancer	0.00408	0.00408	CcSEcCtD
Capreomycin—Leukopenia—Paclitaxel—ovarian cancer	0.00406	0.00406	CcSEcCtD
Capreomycin—Rash—Topotecan—ovarian cancer	0.00406	0.00406	CcSEcCtD
Capreomycin—Hypersensitivity—Vinorelbine—ovarian cancer	0.00406	0.00406	CcSEcCtD
Capreomycin—Dermatitis—Topotecan—ovarian cancer	0.00405	0.00405	CcSEcCtD
Capreomycin—Rash—Melphalan—ovarian cancer	0.00397	0.00397	CcSEcCtD
Capreomycin—Dermatitis—Melphalan—ovarian cancer	0.00397	0.00397	CcSEcCtD
Capreomycin—Hypokalaemia—Epirubicin—ovarian cancer	0.00392	0.00392	CcSEcCtD
Capreomycin—Eosinophilia—Epirubicin—ovarian cancer	0.00369	0.00369	CcSEcCtD
Capreomycin—Hypokalaemia—Doxorubicin—ovarian cancer	0.00363	0.00363	CcSEcCtD
Capreomycin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00363	0.00363	CcSEcCtD
Capreomycin—Rash—Vinorelbine—ovarian cancer	0.00347	0.00347	CcSEcCtD
Capreomycin—Dermatitis—Vinorelbine—ovarian cancer	0.00347	0.00347	CcSEcCtD
Capreomycin—Leukopenia—Docetaxel—ovarian cancer	0.00344	0.00344	CcSEcCtD
Capreomycin—Eosinophilia—Doxorubicin—ovarian cancer	0.00341	0.00341	CcSEcCtD
Capreomycin—Renal failure—Epirubicin—ovarian cancer	0.00326	0.00326	CcSEcCtD
Capreomycin—Pain—Paclitaxel—ovarian cancer	0.00317	0.00317	CcSEcCtD
Capreomycin—Thrombocytopenia—Docetaxel—ovarian cancer	0.00307	0.00307	CcSEcCtD
Capreomycin—Renal failure—Doxorubicin—ovarian cancer	0.00302	0.00302	CcSEcCtD
Capreomycin—Urticaria—Paclitaxel—ovarian cancer	0.00294	0.00294	CcSEcCtD
Capreomycin—Body temperature increased—Paclitaxel—ovarian cancer	0.00293	0.00293	CcSEcCtD
Capreomycin—Tinnitus—Epirubicin—ovarian cancer	0.00278	0.00278	CcSEcCtD
Capreomycin—Hypersensitivity—Paclitaxel—ovarian cancer	0.00273	0.00273	CcSEcCtD
Capreomycin—Pain—Docetaxel—ovarian cancer	0.00268	0.00268	CcSEcCtD
Capreomycin—Tinnitus—Doxorubicin—ovarian cancer	0.00257	0.00257	CcSEcCtD
Capreomycin—Body temperature increased—Docetaxel—ovarian cancer	0.00248	0.00248	CcSEcCtD
Capreomycin—Rash—Paclitaxel—ovarian cancer	0.00233	0.00233	CcSEcCtD
Capreomycin—Dermatitis—Paclitaxel—ovarian cancer	0.00233	0.00233	CcSEcCtD
Capreomycin—Vertigo—Epirubicin—ovarian cancer	0.00233	0.00233	CcSEcCtD
Capreomycin—Leukopenia—Epirubicin—ovarian cancer	0.00232	0.00232	CcSEcCtD
Capreomycin—Hypersensitivity—Docetaxel—ovarian cancer	0.00231	0.00231	CcSEcCtD
Capreomycin—Vertigo—Doxorubicin—ovarian cancer	0.00216	0.00216	CcSEcCtD
Capreomycin—Leukopenia—Doxorubicin—ovarian cancer	0.00215	0.00215	CcSEcCtD
Capreomycin—Thrombocytopenia—Epirubicin—ovarian cancer	0.00207	0.00207	CcSEcCtD
Capreomycin—Rash—Docetaxel—ovarian cancer	0.00198	0.00198	CcSEcCtD
Capreomycin—Dermatitis—Docetaxel—ovarian cancer	0.00198	0.00198	CcSEcCtD
Capreomycin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00192	0.00192	CcSEcCtD
Capreomycin—Pain—Epirubicin—ovarian cancer	0.00181	0.00181	CcSEcCtD
Capreomycin—Urticaria—Epirubicin—ovarian cancer	0.00168	0.00168	CcSEcCtD
Capreomycin—Pain—Doxorubicin—ovarian cancer	0.00168	0.00168	CcSEcCtD
Capreomycin—Body temperature increased—Epirubicin—ovarian cancer	0.00167	0.00167	CcSEcCtD
Capreomycin—Hypersensitivity—Epirubicin—ovarian cancer	0.00156	0.00156	CcSEcCtD
Capreomycin—Urticaria—Doxorubicin—ovarian cancer	0.00156	0.00156	CcSEcCtD
Capreomycin—Body temperature increased—Doxorubicin—ovarian cancer	0.00155	0.00155	CcSEcCtD
Capreomycin—Hypersensitivity—Doxorubicin—ovarian cancer	0.00144	0.00144	CcSEcCtD
Capreomycin—Rash—Epirubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Capreomycin—Dermatitis—Epirubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Capreomycin—Rash—Doxorubicin—ovarian cancer	0.00124	0.00124	CcSEcCtD
Capreomycin—Dermatitis—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
